[Federal Register Volume 71, Number 220 (Wednesday, November 15, 2006)]
[Notices]
[Pages 66533-66534]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-19263]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-07-0009]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail 
to [email protected]. Send written comments to CDC Desk Officer, Office of 
Management and Budget, Washington, DC or by fax to (202) 395-6974. 
Written comments should be received within 30 days of this notice.

Proposed Project

    National Disease Surveillance Program I--Case Reports--Revision--
(OMB No. 0920-0009), National Center for Infectious Diseases (NCID), 
Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    Formal surveillance of 19 separate reportable diseases has been 
ongoing to meet the public demand and scientific interest in accurate, 
consistent, epidemiologic data. These ongoing disease reports include: 
Active Bacterial Core Surveillance (ABCs), Creutzfeldt-Jakob 
Disease(CJD), Cyclospora, Dengue, Hantavirus, Idiopathic CD4+T-
lymphocytopenia, Kawasaki Syndrome, Legionellosis, Lyme disease, 
Malaria, Plague, Q Fever, Reye Syndrome, Tick-borne Rickettsial 
Disease, Trichinosis, Tularemia, Typhoid Fever, and Viral Hepatitis. 
Tularemia and Methicillin-Resistant Staphylococcus aureaus (MRSA) are 
new additions to this submission. Case report forms from state and 
territorial health departments enable CDC to collect demographic, 
clinical, and laboratory characteristics of cases of these diseases. 
This information is used to direct epidemiologic investigations, 
identify and monitor trends in reemerging infectious diseases or 
emerging modes of transmission, to search for possible causes or 
sources of the diseases, and develop guidelines for prevention and 
treatment. The data collected will also be used to recommend target 
areas most in need of vaccinations for selected diseases and to 
determine development of drug resistance.
    Because of the distinct nature of each of the diseases, the number 
of cases reported annually is different for each. There is no cost to 
respondents other than their time. The total annual burden hours are 
13,371.

                                       Estimate of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                      Number
                      Form                           Number of      responses/         Total       Hrs/response
                                                    respondents     respondent       responses
----------------------------------------------------------------------------------------------------------------
ABCs............................................             329           21              6,909           10/60
ABCs Invasive MRSA..............................              18          256              4,608           10/60

[[Page 66534]]

 
CJD.............................................              20            2                 40           20/60
Cyclosporiasis..................................              55           10                550           15/60
Dengue Case Investigation.......................              55          182             10,010           15/60
Hantavirus Pulmonary Syndrome...................              46            3                138           20/60
Idiopathic CD4+T-lymphocytopenia................              10            2                 20           10/60
Kawasaki Syndrome...............................              55            8                440           15/60
Legionellosis Case Report.......................              23           11.7              269           20/60
Lyme Disease Report.............................              52          385             20,020           10/60
Malaria Case Surveillance Report................              55           20              1,100           15/60
Plague Case Investigation Report................              55            0.20              11           20/60
Q Fever.........................................              55            1                 55           10/60
Reye Syndrome Case Surveillance Report..........              50            1                 50           20/60
Tick-borne Rickettsial Disease Case Report......              55           18                990           10/60
Trichinosis Surveillance Case Report............              55             .45              25           20/60
Tularemia.......................................              55            2.2              121           20/60
Typhoid Fever Surveillance Report...............              55            6                330           20/60
Viral Hepatitis Case Record.....................              55          200             11,000           25/60
----------------------------------------------------------------------------------------------------------------


    Dated: November 8, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
[FR Doc. E6-19263 Filed 11-14-06; 8:45 am]
BILLING CODE 4163-18-P